Navigating Post-Brexit Challenges for British and European Businesses

The UK has given the green light to the Oxford AstraZeneca Covid19 vaccine. It’s cheaper and easier to store than some of the alternatives - and the hope is that will make it easier to distribute globally. However, there are worries that production capacity and an unwillingness to share intellectual data might mean the poorest in the world won’t get the immunisation. We speak to Anna Marriott of Oxfam. Also on the show we’ll be mulling over the Brexit deal. We get the view from businesses both sides of the Channel about what the future will bring now the UK and EU have a new trade relationship. We also hear from former EU trade commissioner Cecilia Malmstrom who tells us what effect the divorce will have on the rest of the union. As the rest of the world continues to struggle with Covid 19, China is getting back to normal. We hear from Wuhan and Shanghai. Plus, food businesses discuss how they’ve adapted to survive during the pandemic. Business Weekly is presented by Lucy Burton and produced by Clare Williamson. (Image:University of Oxford researcher in a laboratory at the Jenner Institute, working on the coronavirus vaccine. Image credit: John Cairns/University of Oxford/PA Wire)